Shinhung Co., Ltd (KRX:004080)
South Korea
· Delayed Price · Currency is KRW 14,750
0.00 (0.00%)
At close: Apr 16, 2025, 3:30 PM KST
Shinhung Revenue
In the year 2024, Shinhung had annual revenue of 101.76B KRW, down -9.50%. Shinhung had revenue of 26.69B in the quarter ending December 31, 2024, a decrease of -7.24%.
Revenue
101.76B
Revenue Growth
-9.50%
P/S Ratio
1.36
Revenue / Employee
508.78M
Employees
200
Market Cap
137.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 101.76B | -10.69B | -9.50% |
| Dec 31, 2023 | 112.44B | -5.73B | -4.85% |
| Dec 31, 2022 | 118.18B | -8.68B | -6.84% |
| Dec 31, 2021 | 126.85B | 10.20B | 8.74% |
| Dec 31, 2020 | 116.65B | -6.36B | -5.17% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| PharmaResearch | 350.12B |